Shenzhen New Industries Hits Day Low at CNY 49.85 Amid Price Pressure

Shenzhen New Industries Biomedical Engineering Co., Ltd. experienced a notable decline today, with the stock dropping by 4.14% on March 19, 2026. The stock reached an intraday low of CNY 49.85, reflecting ongoing challenges in its market performance. Over the past week, the stock has seen a decrease of 7.76%, while its monthly performance shows a decline of 3.9%. In the longer term, Shenzhen New Industries has faced significant headwinds, with a one-year performance down by 16.7% compared to the China Shanghai Composite, which has gained 16.93% over the same period. Year-to-date, the stock is down 11.08%, further highlighting its struggles against the broader market trends. Financial metrics indicate a market capitalization of CNY 36,352 million, with a P/E ratio of 32.00 and a dividend yield of 2.81%. However, the company has reported a negative return of -14.10% over the last year and has underperformed the China Shanghai Composite across various time frames. These factors contribute to a challenging outlook for Shenzhen New Industries in the competitive pharmaceuticals and biotechnology sector.